ADAPTIN BIO ANNOUNCES OPENING OF ENROLLMENT IN A PHASE 1 CLINICAL TRIAL EVALUATING TREATMENT OF MALIGNANT BRAIN TUMORS WITH APTN-101

Reuters · 2d ago

Please log in to view news